CROI 2020 Program and Conference Information

General Information

CONFERENCE INFORMATION Overview CROI was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases.The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI is the preeminent HIV research meeting in the world and includes up to 4000 HIV research and care leaders internationally. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in CROI is largely supported by participant registration fees. CROI registration fees cover all hosted attendee meals (including the welcome reception) and travel expenses for invited participants (eg, speakers, leaders, moderators, and CROI PC members), as well as selected meeting materials and other conference expenses. CROI seeks grants from commercial companies, particularly from companies with competing products.These companies have no input in or control over the selection of faculty or content of the CME portions of the program or abstract review and selection processes. Commercial support is used to cover some of the costs of the conference venue, audiovisual services, and other conference expenses. CROI 2020 received grant support commitments from the following commercial companies: HIV and AIDS research. Conference Support

General Information

PLATINUM SUPPORTERS Gilead Sciences, Inc. Janssen Therapeutics

Merck & Co., Inc. ViiV Healthcare

Additional support has been provided by AbbVie Inc. Theratechnologies Inc.

CROI 2020 18